Trials / Completed
CompletedNCT07308652
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood
The Effect of Multiple Doses of Itraconazole on the Single-dose Pharmacokinetics of BI 764198 Following Oral Administration in Healthy Male Trial Participants (an Open-label, Non-randomised, Two-period, Fixed-sequence Design Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find out whether a medicine called itraconazole changes the amount of another medicine called BI 764198 in the blood. Some people may take more than 1 medicine at a time. Therefore, it is important to understand how medicines influence each other. This study will help us learn more about how BI 764198 works.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 764198 | BI 764198 |
| DRUG | Itraconazole | Itraconazole |
Timeline
- Start date
- 2026-02-09
- Primary completion
- 2026-03-24
- Completion
- 2026-04-10
- First posted
- 2025-12-30
- Last updated
- 2026-04-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07308652. Inclusion in this directory is not an endorsement.